-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
↵
Recently, after review, the State Medical Products Administration approved the registration of
the innovative product "blood flow directed dense mesh stent" produced by Eco Medical Device (Beijing) Co.
, Ltd.
the innovative product "blood flow directed dense mesh stent" produced by Eco Medical Device (Beijing) Co.
, Ltd.
Implants for flow-directed mesh stents are cylindrical self-expanding stents woven from self-expanding cobalt-chromium alloy and platinum-tungsten alloy wire
.
The conveying system consists of
push rod, stainless steel coil, funnel, support pad, braided tube, marking ring, platinum coil, warning mark, heat shrink tube, adhesive.
The innovation of this product is the active assisted expansion from the inside of the stent using a mechanical balloon in the delivery system, pushing the stent to the treatment site and recycling the stent when needed
.
.
The conveying system consists of
push rod, stainless steel coil, funnel, support pad, braided tube, marking ring, platinum coil, warning mark, heat shrink tube, adhesive.
The innovation of this product is the active assisted expansion from the inside of the stent using a mechanical balloon in the delivery system, pushing the stent to the treatment site and recycling the stent when needed
.
The product is used in adult patients with internal carotid artery (petrous segment to end) and vertebral artery unruptured sac-shaped or spindle-shaped wide neck (aneurysm width ≥4 mm or tumor/aneurysm ratio <2) aneurysms with a diameter of ≥ 2.
0 mm and a ≤ of 5.
6 mm
.
The launch of the product will bring new treatment options
to patients.
0 mm and a ≤ of 5.
6 mm
.
The launch of the product will bring new treatment options
to patients.
The drug regulatory department will strengthen the post-market supervision of the product to protect the safety
of patients' devices.
of patients' devices.
